Hyaluronic acid: Perspectives in lung diseases

Handbook of Experimental Pharmacology

Volumn 207, Issue , 2012, Pages 385-401

  Allegra, Luigi ^a   Patrona, Sabrina Della ^b   Petrigni, Giuseppe ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b IRCCS   (Italy)

Author keywords

High molecular weight; Hyalurnic acid; Lung diseases

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CHONDROITIN SULFATE; DERMATAN SULFATE; ENOXAPARIN; GLUCOCORTICOID; GLYCOSAMINOGLYCAN; HEPARAN; HEPARIN; HYALURONIC ACID; KERATAN SULFATE; PROTEOGLYCAN;

ADD ON THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHOSPASM; CHEMOTAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DRUG MECHANISM; DRUG STRUCTURE; ELASTOLYSIS; EXERCISE TEST; EXTRACELLULAR MATRIX; FORCED EXPIRATORY VOLUME; HUMAN; HYDRATION; INHALATION TEST; LUNG DISEASE; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG PARENCHYMA; MOLECULAR WEIGHT; NONHUMAN; OSMOLARITY; PLEIOTROPY; POLYMERIZATION; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; SINGLE DRUG DOSE; TISSUE REPAIR; ANIMAL; LUNG; METABOLISM; REVIEW;

ANIMALS; HUMANS; HYALURONIC ACID; LUNG; LUNG DISEASES;

EID: 84861898385     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-23056-1_17     Document Type: Article

References (87)

1. Ahmed T, Abraham WM, D'Brot J (1992) Effects of inhaled heparin on immunologic and nonimmunologic bronchoconstriction responses in sheep. Am Rev Respir Dis 145:566-570
2. Ahmed T, Garrigo J, Danta I (1993) Preventing bronchoconsriction in exercise-induced asthma with inhaled heparin. N Engl J Med 329:90-95
3. Ahmed T, Gonzales BJ, Danta I (1999) Prevention of exercise-induced bronchoconstriction by inhaled low molecular weight heparin. Am J Respir Crit Care Med 160:576-581
4. Ahmed T, Hallmon J, Abraham WM (1991) The effect of heparin on immunologically-induced tracheal smooth muscle contraction in allergic sheep. Am Rev Respir Dis 143(Suppl):A360, abstract
5. Ahmed T, Syriste T, Mendelssohn R, Sorace D, Mansour E, Lansing M, Abraham WM, Robinson MJ (1994) Heparin prevents antigen-induced airway hyperresponsiveness: interference with !P3-mediated mast cell degranulation? J Appl Physiol 76:893-901
6. Allegra L, Abraham WM, Fasano V, Petrigni G (2008) Methacholine challenge in asthmatics is protected by aerosolised hyaluronan at high (1,000 kDa) but not low (300 kDa) molecular weight. Ital J Chest Dis 62:297-301
7. Allegra L, Bianco S, Petrigni G, Robuschi M (1974) Lo sforzo muscolare e la nebulizzazione ultrasonica di H2O come test di provocazione aspecifica del broncospasmo. In: Pasargiklian M, Bocca E (eds) Progressi in Medicina Respiratoria. Terme di Sirmione, Sirmione, pp 81-86
8. Allegra L, Bianco S (1980) Non-specific bronchoreactivity obtained with an ultrasonic aerosol of distilled water. Eur J Respir Dis 61(Suppl 106):41-49
9. Allegra L, Dal Negro R (1993) Physical agents in bronchial provocation tests: nebulised hypoosmolar aerosol. In: Allegra L, Braga PC, Dal Negro R (eds) Methods in asthmology. Springer, Berlin, pp 219-225
10. Allegra L, Della Patrona S, Comi A, Fasano V, Longo L, Terzano C, Petrigni G (2006) Aerosols of hyaluronan partially prevent bronchoconstriction induced by ultrasonically nebulised distilled water in asthmatics. Ital J Chest Dis 60:243-248
11. American Thoracic Society (2000) Guidelines for methacholine and exercise challenge testing 1999. Am J Respir Crit Care Med 161:309-329
12. Anderson SD (1985) Bronchial challenge by ultrasonically nebulized aerosols. Clin Rev Allergy 3:427-439
13. Anderson SD, Brannan JD (2004) Methods for indirect challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Paediatr Drugs 6:161-175
14. Anderson SD, Schoeffel RE, Finney M (1983) Evaluation of ultrasonic distilled water for provocation testing in patients with asthma. Thorax 38:284-291
15. Anderson SD, Schoeffel RE, Follet R, Perry CP, Daviskas E, Kendall M (1982) Sensitivity to heat and water loss at rest and during exercise in asthmatic patients. Eur J Respir Dis 63:459-471
16. Baccarani-Contri M, Vincenzi D, Cicchetti F, Mori G, Pasquali-Ronchetti I (1990) Immunocytochemical localization of proteoglycans within normal elastin fibers. Eur J Cell Biol 53:305-312
17. Balasz A, Laurent TC, Jeanlo RW (1986) Nomenclature of hyaluronic acid. Biochem J 235:903, abstract
18. Bert JL, Pierce RH (1984) The interstitium and microvascular exchange. In: Renkin EM (ed) Handbook of physiology. Section 2: the cardiovascular system, Vol. IV, Pt 1: Microcirculation. American Physiological Society, Bethesda, pp 521-547
19. Bhattacharya J, Cruz T, Bhattacharya S, Bray BA (1989) Hyaluronan affects extravascular water in lungs of unanesthetized rabbits. J Appl Physiol 66:2595-2599
20. Blackwood RA, Cantor JO, Moret J, Mandl I, Turino GM (1983) Glycosaminoglycan synthesis in endotoxin-induced lung injury. Proc Soc Exp Biol Med 174:343-349
21. Bothner H, Wyk O (1987) Rheology of hyaluronate. Acta Otorinolaryngol 442(suppl):25-30
22. Braya PC, Allegra L. (1988) Methods in Bronchial Mucology, Raven Press, New York
23. Brown RA, Allegra L, Matera MG, Page CP, Cazzola M (2006) Additional clinical benefits of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination. Pulm Pharmacol Ther 19:419-424
24. Bush A (2008) How early do airway inflammation and remodelling occur? Allergol Int 57:11-19
25. Cade JF, Pain MCF (1972) Lung function in provoked asthma: response to inhaled urea, methacholine and isoprenaline. Clin Sci 43:759-769
26. Cantor JO, Cerreta JM, Keller S, Turino GM (1995) Modulation of airspace enlargement in elastase-induced emphysema by intratracheal instillment of hyaluronidase and hyaluronic acid. Exp Lung Res 21:423-436
27. Cheney FW jr, Butler J (1968) The effect of ultrasonically produced aerosols on airway resistance in man. Anesthesiology 29:1099-1106
28. Cheney FW jr, Butler J (1970) The effects of ultrasonica aerosols on the total respiratory resistance in the intubated patient. Anesthesiology 32:456-458
29. Cleland RL, Wang JL (1970) Tonic polysaccharides. III: dilute solution properties of hyaluronic acid fraction. Biopolymers 9:799-810
30. Dahl R (2008) Glycosaminoglycans: therapeutic opportunities for hyaluronan in respiratory diseases. Ital J Chest Dis 62:289-296
31. Daviskas E, Anderson SD (2006) Hyperosmolar agents and clearance of mucus in the diseased airway. J Aerosol Med 19:100-109
32. Dentener MA, Vernooy JH, Hendriks S et al (2005) Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax 60:114-119
33. Elwood RK, Hogg JC, Pare PD (1982) Airway response to osmolar challenge in asthma. Am Rev Respir Dis 61(Suppl):125, abstract
34. Eschenbacher WL, Boushey HA, Sheppard D (1984) Alteration in osmolarità of inhaled aerosols cause bronchoconstriction and cough, but of a permanent anion causes cough alone. Am Rev Respir Dis 129:211-215
35. Fraser JR, Laurent TC, Laurent UB (1997) Hyaluronan: its nature, distribution, function and turnover. J Intern Med 242:27-33
36. Fraser JRE, Kimpton WG, Laurent TC, Cahill RN, Vakakis N (1988) Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 256:153-158
37. Fryer A, Huang YC, Rao G, Jacobi D, Mancilla E, Whorton R et al (1997) Selective O- desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung. J Pharmacol Exp Ther 282:208-219
38. Garrigo J, Danta I, Ahmed T (1996) Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am J Respir Crit Care Med 153:1702-1707
39. Goh LT (1998) Effect of colture conditions on rates of intrinsic hyaluronic acid production by Streptococcus equi spp Zooepidermicus. Biotechnol Lett 16:507-512
40. Goldberg EP, Burns JW, Jacobi Y (1993) Prevention of postoperative adhesion to precoating tissues with diluted sodium hyaluronate solutions. Prog Clin Biol Res 381:191-204
41. Granger HJ, Laine GA, Barnes JE, Lewis RE (1984) Dynamics and control of transmicrovascular fluid exchange. In: Staub NC et al (eds) Edema. Raven, New York, pp 198-228
42. Granger HJ (1981) Physicochemical properties of the extracellular matrix. In: Hargens AR (ed) Tissues fluid pressure and composition. Williams & Wilkins, Baltimore, pp 43-61
43. Hallgren R, Eklund A, Engstrom-Laurent A et al (1985) Hyaluronate in bronchoalveolar lavage fluid: A new marker in sarcoidosis reflecting pulmonary disease. Br Med J 290:1778-1781
44. Haynes BF, Hua-Xin L, Patton KL (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3:347-350
45. Hogg JC, Eggleston PA (1984) Is asthma an epithelial disease? Am Rev Respir Dis 129:207-208
46. Itano N, Sawai T, Yoshida M et al (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274:25085-25092
47. Johnson PR, Roth M, Tamm M et al (2001) Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 164:474-477
48. Keity CM, Whittaker SP, Grant MF, Shuttleworth CA (1992) Type VI collagen microfibrils: evidence for a structural association with hyaluronan. J Cell Biol 118:979-990
49. King SR, Hickerson WL, Proctor KG (1991) Beneficial actions of exogenous hyaluronic acid on wound healing. Surgery 109:76-84
50. Klagas I, Goulet S, Karakiulakis G, Zhong J, Baraket M, Black JL, Papakonstantinou E, Royh M (2009) Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD. Eur Respir J 34:616-628
51. Kunz LIZ, van Rengen ELJ, Sterk PJ (2006) Inhaled hyaluronic acid against exercise-induced broncho-constriction in asthma. Pulm Pharmacol Ther 19:286-291
52. Laurent TC (1970) Structure of hyaluronic acid. In: Balasz EA (ed) Chemistry and molecular biology of the intercellular matrix. Academic, London, pp 703-732
53. Laurent UGB, Reed RK (1991) Turnover of hyaluronan in the tissue. Adv Drug Deliv Rev 7:237-256
54. Lever R, Page C (2001) Glycosaminoglycans, airways inflammation and bronchial inflammation. Pulm Pharmacol Ther 14:249-254
55. Magyar P, Dervaderics M, Tòth A, Lantos A (1983) Inhalation of hypertonic potassium chloride solution: A specific bronchial challenge for asthma. Ital J Chest Dis 37:29-34
56. Marchette LC, Marchette BE, Abraham WM, Wanner A (1985) The effect of systemic hydration on normal and impaired mucociliary function. Pediatr Pulmonol 1:107-111
57. McFadden ER, Lenner KAM, Strohl KP (1986) Postexertional airway rewarming and thermally induced asthma. New insights into pathophysiology and possible pathogenesis. J Clin Invest 78:18-25
58. Meyer K, Palmer JW (1934) The polysaccharide in vitreous humour. J Biol Chem 107:629-634
59. Monzon ME, Casalino-Matsuda SM, Forteza RM (2006) Identification of glycosaminoglycans in human airway secretions. Am J Respir Cell Mol Biol 34:135-141
60. Papakonstantinou E, Karakiulakis G, Eickelberg O et al (1998) A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiology 8:821-830
61. Petrigni G, Allegra L (2006) Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma. Pulm Pharmacol Ther 19:166-171
62. Poole AR, Dieppe P (1994) Biological markers in rheumatoid arthritis. Semin Arthritis Rheum 23:17-31
63. Postma DS, Timens W (2006) Remodelling in asthma and chronic obstructive pulmonary disease. Proc Am Thor Soc 3:434-439
64. Potter PC, Klein M, Weinberg EG (1991) Hydration in severe acute asthma. Arch Dis Child 66:216-299
65. Reed RK, Bowen BD, Bert JL (1989) Microvascular exchange and interstitial volume regulation in the rat: implication of the model. Am J Physiol 257H:2081-2091
66. Reed RK, Laurent UGB (1992) Turnover of hyaluronan in the microcirculation. Am Rev Respir Dis 146:S37-S39
67. Schmid K, Grundboeck-Jusco J, Kimura A, Tschopp FA, Zollinger R, Binette JP, Lewis W, Hayashi S (1982) The distribution of the glycosaminoglycans in the anatomic components of the lung and the changes in concentration of these macromolecules during development and aging. Biochem Biophys Acta 716:178-187
68. Schoeffel RE, Anderson SD, Altounyan RE (1981) Bronchial hyperreactity in response to inhalation of ultrasonically nebulized solutions of distilled water and saline. Br Med J 283:1285-1287
69. Scuri M, Abraham WM, Botvinnikova Y, Forteza R (2001) Hyaluronic acid blocks porcine pancreatic elastase (PPE)-induced broncho-constriction in sheep. Am J Crit Care Med 164:1855-1859
70. Scuri M, Abraham WM (2003) Hyaluronan blocks human neutrophil elastase (HNE)-induced air way responses in sheep. Pulm Pharmacol Ther 16:335-340
71. Scuri M, Sabater J, Abraham WM (2007) Hyaluronan blocks porcine pancreatic elastase-induced mucociliary dysfunction in allergic sheep. J Appl Physiol 102:2324-2331
72. Shaw RJ, Anderson SD, Durham SR, Taylor KM, Schoeffel RE, Green W, Torzillo P, Kay AB (1985) Mediators of hypersensitivity and fog-induced asthma. Allergy 40:48-57
73. Sheppard D, Rtzk N, Boushey HA (1983) Mechanism of cough and bronchoconstriction induced by distilled water aerosol. Am Rev Respir Dis 127:691-694
74. Sheppard D, Eschenbacher WL (1984) Respiratory water loss as a stimulus to exercise-induced bronchoconstriction. J Allergy Clin Immunol 73:640-642
75. Singleton R, Moel DI, Cohn RA (1986) Preliminary observation of impaired water excretion in treated status asthmaticus. Am J Dis Child 140:59-61
76. Smedrson B, Perthof H, Gustavson S, Laurent TC (1990) Scavenger function of the liver endothelial cell. Biochem J 266:313-327
77. Toole BP (1990) Hyaluronan and its binding proteins, hyaladerins. Curr Opin Cell Biol 2:839-844
78. Toole BP (1991) Glycosaminoglycans and morphogenesis. In: Hay ED (ed) Cell biology and extracellular M2trix. Plenum, New York, pp 259-294
79. Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528-539
80. Tranfa CM, Vatrella A, Parrella R, Pelaia G, Bariffi F, Marsico S (2001) Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics. Eur J Clin Pharmacol 57:59
81. Turino GM (1986) The pulmonary parenchyma: A dynamic matrix (J. Burns Amberson lecture). Am Rev Respir Dis 132:1324-1334
82. Turino GM (2003) Hyaluronan in respiratory injury and repair. Am J Respir Crit Care Med 167:1169-1175
83. Underhill CB (1992) CD44: the hyaluronan receptor. J Cell Sci 103:193-198
84. Valerio G, Salerno FG, Bracciale P (2007) The i.v. infusion of mannitol decreases air way responsiveness to methacholine in asthma. Respir Physiol Neurobiol 156:374-377
85. Venge P, Pedersen B, Hakansson L, Hallgren R, Lindblad G, Dahl R (1996) Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis. Am J Respir Crit Care Med 153:312-316
86. Vitanzo PC jr, Sennett BJ (2006) Hyaluronans: is clinical effectiveness dependent on molecular weight? Am J Orthop 35:421-428
87. Yang B, Zhang L, Turley EA (1993) Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem 268:8617-8623